论文部分内容阅读
本文分析了新的医防合作模式下继续坚持“肺结核患者的不住院化疗”策略的必要性。从结核杆菌的持留性和控制传染源的角度分析,普通肺结核患者没有必要进行长期住院治疗。从患者、医保部门、定点医院三个利益相关方分析,不住院化疗能有效减轻患者诊疗负担、降低医保基金风险、优化定点医院诊疗资源配置。有效实施“肺结核患者的不住院化疗”策略需要调整定点医院住院诊疗资源配置,强化患者的全程管理,改变医保费用支付方式,促进医院主动转型。
This article analyzes the necessity of continuing to adhere to the strategy of “no hospitalized chemotherapy for tuberculosis patients” under the new model of medical cooperation. From the perspective of the persistence of Mycobacterium tuberculosis and the source of infection control, ordinary tuberculosis patients do not need long-term hospitalization. From the analysis of patients, medical insurance departments and designated hospitals, non-hospitalized chemotherapy can effectively reduce the burden of patient consultation, reduce the risk of medical insurance fund and optimize the allocation of medical resources in designated hospitals. Effective implementation of “tuberculosis patients do not hospital chemotherapy ” strategy needs to adjust the fixed hospital inpatient resources allocation, strengthen the patient’s full management, change the medical insurance fee payment, promote the hospital initiative transformation.